Galapagos NV - ADR (GLPG) цена на акцијата и вести

Почетна страницаGLPG • NASDAQ

Galapagos NV - ADR

33,48 $

21 јан., 08:19:59 GMT-5 · USD · NASDAQ · Оградување

АкцијаСе тргува во САД

Прет. посл. цена

33,48 $

Годишен опсег

22,36 $ - 37,78 $

Пазарна капитализација

2,10 милј. USD

Просечен обем

110,64 илј.

Сооднос Ц/З

Принос од дивиденда

Вести за пазарот

PR Newswire

пред 1 час

Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.

HC Wainwright Reaffirms "Buy" Rating for Telix Pharmaceuticals (NASDAQ:TLX)

Yahoo Finance Singapore

пред 1 час

AZIO AI and Envirotech Vehicles (NASDAQ: EVTV) Execute Scalable AI Infrastructure Strategy Designed for Multi-Megawatt Expansion

NBCUniversal Rings the Closing Bell

Stock Market Today: Dow, S&P 500 and Nasdaq struggle to rally after sharp sell-off even as government bonds recover some poise; gold hits new record above $4,850; Trump to give Davos speech.

TipRanks

пред 7 минути

MINISO Discloses January 16 Share Buyback on NYSE Under Ongoing Repurchase Program

Информации

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia

Главен извршен директор

Основана на

1999

Вебсајт

glpg.com

Вработени

558